Increased gut glucagon release as pathogenetic factor in reactive hypoglycaemia?

Oral 2-oleyl glyceryl ether improves glucose tolerance in mice through the GPR119 receptor.

BioFactors (Oxford, England)·2016

Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion.

Diabetes, obesity & metabolism·2016

Effects of RYGB on energy expenditure, appetite and glycaemic control: a randomized controlled clinical trial.

International journal of obesity (2005)·2015

Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.

International journal of obesity (2005)·2013

Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study.

Diabetologia·2012

Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.

Obesity surgery·2012

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

A case report of jejunogastric intussusception complicated by torsion: 17 years after subtotal gastrectomy.

Frontiers in surgery·2026

Acute oesophageal necrosis following ethyl-induced emesis: A Case Report.

Acta gastro-enterologica Belgica·2026

Divergent Radiomolecular Phenotype of Spindle Cell Lipoma: Intense 68Ga-PSMA Uptake in a Lesion With Mild 18F-FDG Avidity.

Clinical nuclear medicine·2026

ORAL AND GASTRIC PLAQUES, PAPILLOMAS, SQUAMOUS CELL CARCINOMAS AND PAPILLOMAVIRUSES IN SLENDER-HORNED GAZELLES (<i>GAZELLA LEPTOCEROS</i> ).

Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians·2026

Eosinophilic Gastritis with Localized Eosinophilic Infiltration Presenting as a Solitary Deep-Penetrating Gastric Ulcer Refractory to Potassium-Competitive Acid Blocker.

Case reports in gastroenterology·2026

Incidental <sup>68</sup> Ga -DOTATATE Uptake in Metastatic Clear Cell Renal Cell Carcinoma: A Case Report.

World journal of nuclear medicine·2026

Related Experiment Videos

Increased gut glucagon release as pathogenetic factor in reactive hypoglycaemia?

Related Concept Videos

Oral 2-oleyl glyceryl ether improves glucose tolerance in mice through the GPR119 receptor.

Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion.

Effects of RYGB on energy expenditure, appetite and glycaemic control: a randomized controlled clinical trial.

Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.

Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study.

Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

A case report of jejunogastric intussusception complicated by torsion: 17 years after subtotal gastrectomy.

Acute oesophageal necrosis following ethyl-induced emesis: A Case Report.

Divergent Radiomolecular Phenotype of Spindle Cell Lipoma: Intense 68Ga-PSMA Uptake in a Lesion With Mild 18F-FDG Avidity.

ORAL AND GASTRIC PLAQUES, PAPILLOMAS, SQUAMOUS CELL CARCINOMAS AND PAPILLOMAVIRUSES IN SLENDER-HORNED GAZELLES (<i>GAZELLA LEPTOCEROS</i> ).

Eosinophilic Gastritis with Localized Eosinophilic Infiltration Presenting as a Solitary Deep-Penetrating Gastric Ulcer Refractory to Potassium-Competitive Acid Blocker.

Incidental <sup>68</sup> Ga -DOTATATE Uptake in Metastatic Clear Cell Renal Cell Carcinoma: A Case Report.

Related Experiment Videos

Increased gut glucagon release as pathogenetic factor in reactive hypoglycaemia?

Related Concept Videos

Related Articles